Literature DB >> 11555869

Analysis of urinary nucleosides. II. Comparison of mass spectrometric methods for the analysis of urinary nucleosides.

E Dudley1, F Lemiere, W Van Dongen, J I Langridge, S El-Sharkawi, D E Games, E L Esmans, R P Newton.   

Abstract

Qualitative and quantitative analyses of urinary nucleosides have diagnostic potential as tumour markers. We have developed separation techniques linked to mass spectrometric detection in order to overcome the problems associated with past identification and quantitation methods. The three methods of analysis utilised were: gas chromatography/mass spectrometry (GC/MS), high-performance liquid chromatography/ion-trap mass spectrometry (HPLC/ITMS) and capillary liquid chromatography/triple quadrupole mass spectrometry (CapLC/TQMS). Here we compare the relative effectiveness of each of the techniques for subsequent application in the systematic study of urinary nucleoside profiles in cancer patients. All three methods proved to be valuable techniques for such urinary nucleoside analyses, and a combination rather than one single choice is concluded as the ideal. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11555869     DOI: 10.1002/rcm.428

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  2 in total

1.  A nano-chip-LC/MSn based strategy for characterization of modified nucleosides using reduced porous graphitic carbon as a stationary phase.

Authors:  Anders Michael Bernth Giessing; Lincoln Greyson Scott; Finn Kirpekar
Journal:  J Am Soc Mass Spectrom       Date:  2011-04-15       Impact factor: 3.109

Review 2.  The state-of-the-art determination of urinary nucleosides using chromatographic techniques "hyphenated" with advanced bioinformatic methods.

Authors:  Wiktoria Struck; Małgorzata Waszczuk-Jankowska; Roman Kaliszan; Michał J Markuszewski
Journal:  Anal Bioanal Chem       Date:  2011-02-27       Impact factor: 4.142

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.